Abstract
In Iran women are less likely than men to use drugs, but suffer greater morbidity, are stigmatised, and are less likely to seek treatment. In 2007, we established a clinic in Tehran for drug using women. We report here on our study of the 97 women who registered in the first year of operation. We profiled these women: demographics, drug use, risk behaviour, and use of services. The clinic's services were heavily used. We interviewed clients and staff about the clinic and learned that intensive help is needed for women trying to recover from years of drug use. We conclude that female drug users will make use of harm reduction services if they are provided in a setting designed and operated for women.
Commentary jphp.2011.11, available at www.palgrave-journals.com/jphp/, relates to this Article.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
United Nations Office on Drugs and Crime. (2009) Afghanistan Opium Survey, United Nations, Vienna, 1 September. http://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_opium_survey_2009_summary.pdf, accessed June 2010.
United Nations Office on Drugs and Crime. (2006) World Drug Report 2006, http://www.unodc.org/unodc/en/data-and-analysis/WDR-2006.html, accessed February 2011.
Mokri, A. (2002) Brief overview of the status of drug abuse in Iran, http://www.ams.ac.ir/aim/0253/0253184.htm, accessed January 2011.
Gouya, M.M. (2005) National Report on HIV and AIDS Cases. Tehran: Disease Management Center, Ministry of Health and Medical Education, Islamic Republic of Iran.
Razani, N. et al (2007) HIV risk behavior among injection drug users in Tehran, Iran. Addiction 102 (9): 1472–1482.
Dolan, K., Kite, B., Black, E., Aceijas, C. and Stimson, G.V. (2007) HIV in prison in low-income and middle-income countries. Lancet Infectious Diseases 7 (1): 32–41.
Kim, W. (2002) Global epidemiology and burden of hepatitis C. Microbes and Infection 4 (12): 1219–1225.
Rahbar, A.R., Rooholamini, S. and Khoshnood, K. (2004) Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. International Journal of Drug Policy 15: 151–155.
Grella, E.G., Scotty, C.K. and Foss, M. (2005) Gender differences in long-term treatment outcomes in Chicago PETS. Journal of Substance Abuse Treatment 28 (Suppl 1): S3–12.
Vazirian, M. et al (2005) Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduction Journal 2: 19.
Razzaghi, E., Nassirimanesh, B., Afshar, P., Ohiri, K., Claeson, M. and Power, R. (2006) HIV/AIDS harm reduction in Iran. The Lancet 5;368 (9534): 434–435.
Day, C., Nassirimanesh, B., Shakeshaft, A. and Dolan, K. (2006) Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran. Harm Reduction Journal 3: 2.
Pincock, S. and Dolan, K. (2008) Lunch with The Lancet. The Lancet 372 (9645): 1213.
Dolan, K., Wodak, A., Hall, W., Gaughwin, M. and Rae, F. (1996) HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales. Addiction Research 4 (2): 151–160.
Day, C., Ross, J. and Dolan, K. (2003) Hepatitis C related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug and Alcohol Review 22 (3): 317–321.
Pinkham, S. and Malinowska-Sempruch, K. (2008) Women, harm reduction and HIV. Reproductive Health Matters 16 (31): 168–181.
Post, J.J., Dolan, K., Whybin, L.R., Carter, I.W.J., Haber, P.S. and Lloyd, A.R. (2001) Acute hepatitis C virus infection in an Australian prison inmate: Tattooing as a possible transmission route. Medical Journal of Australia 174 (4): 183–184.
Dolan, K., Hall, W., Wodak, A. and Gaughwin, M. (1994) Evidence of HIV transmission in an Australian prison. Medical Journal of Australia 6;160 (11): 734.
Dolan, K. and Wodak, A. (1996) An international review of methadone provision in prisons. Addiction Research 4 (1): 85–97.
Dolan, K., Wodak, A. and Hall, W. (1998) Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug and Alcohol Review 17 (2): 153–158.
Dolan, K., Mattick, R.P., Shearer, J., MacDonald, M., Hall, W. and Wodak, A. (2003) A randomized controlled trial of methadone maintenance treatment vs. wait list control in an Australian prison system. Drug and Alcohol Dependence 72 (1): 59–65.
Dolan, K., Shearer, J., White, B., Zhou, J. and Wodak, A. (2005) Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction 100 (6): 820–828.
Acknowledgements
We wish to acknowledge our funders the Drosos Foundation, Switzerland, the staff at Persepolis NGO, our accountant and the research assistants. Special thanks go to the women who have visited our clinic and participated in the research.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study shows why establishment of a methadone treatment clinic for women in Tehran is significant: if the access threshold for services is lowered, uptake among female drug users is dramatic.
Rights and permissions
About this article
Cite this article
Dolan, K., Salimi, S., Nassirimanesh, B. et al. The establishment of a methadone treatment clinic for women in Tehran, Iran. J Public Health Pol 32, 219–230 (2011). https://doi.org/10.1057/jphp.2011.10
Published:
Issue Date:
DOI: https://doi.org/10.1057/jphp.2011.10